Herantis Pharma Oyj
HRPMF · OTC
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,253 | -$2,687 | $2,075 | -$1,795 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$1,257 | -$308 | -$248 | $357 |
| Other Non-Cash | $0 | -$40 | -$3,287 | -$279 |
| Operating Cash Flow | -$3,510 | -$3,035 | -$1,460 | -$859 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $607 |
| Inv. Purchases | $0 | -$1,500 | $0 | $0 |
| Inv. Sales/Matur. | -$0 | $1,026 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$0 | -$474 | $0 | $607 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $4,506 | $1 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2,156 | -$5 | -$11 | -$1 |
| Financing Cash Flow | $2,156 | -$5 | $4,495 | $1 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $0 | -$3,512 | $0 | $3,926 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,989 | $5,501 | $3,926 | $0 |
| End Cash | $635 | $1,989 | $5,503 | $3,926 |
| Free Cash Flow | -$3,510 | -$3,035 | -$1,460 | -$859 |